lanthanum deposition in the upper gastrointestinal tract uisng esophagogastroduodenoscopy

lanthanum deposition in the upper gastrointestinal tract uisng esophagogastroduodenoscopy - lanthanum deposition in the upper GI tract uisng EGD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000022203

Enrollment

Registered

2016-06-01

Start date

2016-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic kidney disease

Interventions

endoscopic and pathological findings in the esophagus, stomach and duodenum from July 2016 to March 2018

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients with CKD taking lanthanum

Exclusion criteria

Exclusion criteria: patients who do not want to undergo EGD patients taking anti-coagulant drugs

Design outcomes

Primary

Measure	Time frame
endoscopic and pathological findings	—

Countries

Japan

Contacts

Public ContactHiroyuki Imaeda

Saitama Medical University Hospital Department of Gastroenterology

imaedahi@saitama-med.ac.jp049-276-1667

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026